GB0223070D0 - Intermediates in the preparation of therapeutic fused bicyclic amino acids - Google Patents

Intermediates in the preparation of therapeutic fused bicyclic amino acids

Info

Publication number
GB0223070D0
GB0223070D0 GBGB0223070.4A GB0223070A GB0223070D0 GB 0223070 D0 GB0223070 D0 GB 0223070D0 GB 0223070 A GB0223070 A GB 0223070A GB 0223070 D0 GB0223070 D0 GB 0223070D0
Authority
GB
United Kingdom
Prior art keywords
intermediates
preparation
amino acids
fused bicyclic
bicyclic amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0223070.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GBGB0223070.4A priority Critical patent/GB0223070D0/en
Publication of GB0223070D0 publication Critical patent/GB0223070D0/en
Priority to JP2004541065A priority patent/JP2006501296A/en
Priority to BR0315046-1A priority patent/BR0315046A/en
Priority to PCT/IB2003/004179 priority patent/WO2004031115A1/en
Priority to MXPA05003638A priority patent/MXPA05003638A/en
Priority to AU2003263487A priority patent/AU2003263487A1/en
Priority to EP03799019A priority patent/EP1551789A1/en
Priority to CA002499863A priority patent/CA2499863A1/en
Priority to US10/677,836 priority patent/US7018818B2/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/608Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a ring other than a six-membered aromatic ring in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/353Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by isomerisation; by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • C07C53/136Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/26Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/20All rings being cycloaliphatic the ring system containing seven carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB0223070.4A 2002-10-04 2002-10-04 Intermediates in the preparation of therapeutic fused bicyclic amino acids Ceased GB0223070D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0223070.4A GB0223070D0 (en) 2002-10-04 2002-10-04 Intermediates in the preparation of therapeutic fused bicyclic amino acids
JP2004541065A JP2006501296A (en) 2002-10-04 2003-09-22 Intermediates in the production of therapeutic fused bicyclic amino acids
BR0315046-1A BR0315046A (en) 2002-10-04 2003-09-22 Intermediates in the preparation of therapeutic fused bicyclic amino acids
PCT/IB2003/004179 WO2004031115A1 (en) 2002-10-04 2003-09-22 Intermediates in the preparation of therapeutic fused bicyclic amino acids
MXPA05003638A MXPA05003638A (en) 2002-10-04 2003-09-22 Intermediates in the preparation of therapeutic fused bicyclic amino acids.
AU2003263487A AU2003263487A1 (en) 2002-10-04 2003-09-22 Intermediates in the preparation of therapeutic fused bicyclic amino acids
EP03799019A EP1551789A1 (en) 2002-10-04 2003-09-22 Intermediates in the preparation of therapeutic fused bicyclic amino acids
CA002499863A CA2499863A1 (en) 2002-10-04 2003-09-22 Intermediates in the preparation of therapeutic fused bicyclic amino acids
US10/677,836 US7018818B2 (en) 2002-10-04 2003-10-02 Intermediates in the preparation of therapeutic fused bicyclic amino acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0223070.4A GB0223070D0 (en) 2002-10-04 2002-10-04 Intermediates in the preparation of therapeutic fused bicyclic amino acids

Publications (1)

Publication Number Publication Date
GB0223070D0 true GB0223070D0 (en) 2002-11-13

Family

ID=9945336

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0223070.4A Ceased GB0223070D0 (en) 2002-10-04 2002-10-04 Intermediates in the preparation of therapeutic fused bicyclic amino acids

Country Status (8)

Country Link
EP (1) EP1551789A1 (en)
JP (1) JP2006501296A (en)
AU (1) AU2003263487A1 (en)
BR (1) BR0315046A (en)
CA (1) CA2499863A1 (en)
GB (1) GB0223070D0 (en)
MX (1) MXPA05003638A (en)
WO (1) WO2004031115A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110818550A (en) * 2019-11-25 2020-02-21 东华理工大学 Method for preparing dextro-ibuprofen through selective enzymatic hydrolysis reaction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2444053C (en) * 2001-04-19 2008-06-17 Warner-Lambert Company Llc Fused bicyclic or tricyclic amino acids

Also Published As

Publication number Publication date
MXPA05003638A (en) 2005-06-03
BR0315046A (en) 2005-08-16
AU2003263487A1 (en) 2004-04-23
JP2006501296A (en) 2006-01-12
EP1551789A1 (en) 2005-07-13
WO2004031115A1 (en) 2004-04-15
CA2499863A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
IL157932A0 (en) Fused bicyclic or tricyclic amino acids
AU2003285091A8 (en) Interferon antagonists useful for the treatment of interferon related diseases
HRP20040709A2 (en) Bicyclic amino acids as pharmaceutical agents
EP1514106A4 (en) Targeted therapeutic proteins
EP1578949A3 (en) Site specific incorporation of keto amino acids into proteins
AU2003270009A8 (en) Oral delivery of modified transferrin fusion proteins
IL173736A0 (en) Process for the preparation of renzapride and intermediates thereof
EP1576169A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
IL168782A (en) Enantiomer (-) of tenatoprazole and the therapeutic use thereof
GB0216972D0 (en) Peptides and peptide derivaties for the treatment of &-synuclein-related diseases
GB0109635D0 (en) Fused bicyclic or tricyclic amino acids
EP1441030A4 (en) Method of purifying recombinant fused protein and method of producing protein using the same
AU2003226899A8 (en) Human diabetes-mediating proteins
AU2003217956A8 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
GB0223070D0 (en) Intermediates in the preparation of therapeutic fused bicyclic amino acids
EP1513549A4 (en) Human prolactin antagonist-angiogenesis inhibitor fusion proteins
EP1549671A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003265845A1 (en) METHODS FOR THE PREPARATION OF Beta-AMINO ACIDS
AU2003250481A1 (en) Therapeutic use of fused bicyclic or tricyclic amino acids
GB0223067D0 (en) Therapeutic use of fused bicyclic or tricyclic amino acids
EP1576168A4 (en) Therapeutic polypeptides nucleic acids encoding same and methods of use
AU2003304034A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003265867A8 (en) A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use
AU2003270424A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
GB0125807D0 (en) Fused bicyclic or tricyclic amino acids

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)